B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CES1

MOLECULAR TARGET

carboxylesterase 1

UniProt: P23141NCBI Gene: 106617 compounds

CES1 (carboxylesterase 1) is targeted by 17 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CES1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1enoxolone4.5796
2lapachone4.3476
3lupeol4.0355
4tanshinone iia3.7441
5dihydrotanshinone i2.8917
6tanshinone i2.8917
7benzil2.4811
8910 phenanthrenequinone2.309
912 naphthoquinone2.309
10acetoxolone2.208
11chloranil2.208
125 iodoisatin2.208
13miltirone2.208
14acenaphthoquinone1.795
15benzoin1.795
16Ursolic Acid0.691
17Oleanolic Acid0.691

About CES1 as a Drug Target

CES1 (carboxylesterase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 17 compounds with documented CES1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CES1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.